Agilent Technologies Inc

Research Agilent Technologies Inc (A) on Bullrun: valuation model: 9.6% undervalued, market cap USD 37.52B, P/E 26.7, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerA
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Valuation signal9.6% undervalued
• Market capUSD 37.52B
• P/E26.7
• Dividend yield0.8%
• Financial periodFY2025
• RevenueUSD 6.95B
• Revenue growth6.7%
• Net incomeUSD 1.30B
• Free cash flowUSD 1.15B
• Gross margin52.4%

Valuation Snapshot

Bullrun's latest valuation model marks Agilent Technologies Inc as 9.6% undervalued; latest market cap is USD 37.52B; P/E is 26.7; dividend yield is 0.8%.

About Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.

Frequently asked questions

Is Agilent Technologies Inc overvalued or undervalued?

Bullrun's valuation model currently marks Agilent Technologies Inc as 9.6% undervalued.

What is Agilent Technologies Inc's market cap?

Agilent Technologies Inc's market capitalization is USD 37.52B.

What is Agilent Technologies Inc's P/E ratio?

Agilent Technologies Inc's price-to-earnings (P/E) ratio is 26.7.

Does Agilent Technologies Inc pay a dividend?

Agilent Technologies Inc has a dividend yield of 0.8%.

What does Agilent Technologies Inc do?

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.